Stoke Therapeutics
STOK
94 hedge funds and large institutions have $855M invested in Stoke Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 16 closing their positions.
74% more capital invested
Capital invested by funds: $492M → $855M (+$362M)
43.66% more ownership
Funds ownership: 52.67% → 96.33% (+44%)
32% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 25
25% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 16
4% more funds holding
Funds holding: 90 → 94 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCA
Octagon Capital Advisors
New York
|
+$11.6M |
| 2 |
CAC
Cowen and Company
New York
|
+$6.19M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.58M |
| 4 |
ABG
Ally Bridge Group
New York
|
+$4.41M |
| 5 |
FPCP
Fort Point Capital Partners
San Francisco,
California
|
+$3.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$3.23M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.81M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.52M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.29M |
| 5 |
Renaissance Technologies
New York
|
-$2.11M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Invesco
Atlanta,
Georgia
| – | -$237K | -9,325 | Closed |
|
102
Voloridge Investment Management
Jupiter,
Florida
| – | -$208K | -8,191 | Closed |
|
103
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| – | -$130K | -5,100 | Closed |
|
|
MAM
104
Meeder Asset Management
Dublin,
Ohio
| – | -$36K | -1,387 | Closed |
|
105
Ensign Peak Advisors
Salt Lake City,
Utah
| – | -$33K | -1,294 | Closed |
|
|
PCM
106
Penserra Capital Management
Orinda,
California
| – | -$21K | -840 | Closed |
|
|
OSAM
107
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$16K | -640 | Closed |
|
108
Simplex Trading
Chicago,
Illinois
| – | -$7K | -222 | Closed |
|
|
RE
109
RBC Europe
London,
United Kingdom
| – | -$2.34K | -92 | Closed |
|
|
S
110
SignatureFD
Atlanta,
Georgia
| – | -$1K | -33 | Closed |
|
STOK Hedge Fund Activity: Q4 2021 in Review
94 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q4 2021, worth a combined $855M — up 74% from $492M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new STOK positions and 16 closed out — a net gain of 4 holders — while 33 added to existing stakes and 25 trimmed.
The largest buyer was Octagon Capital Advisors, adding an estimated $11.6M. The largest seller was Redmile Group, cutting an estimated $3.23M.
- 94 institutional investors held Stoke Therapeutics (STOK) as of Q4 2021, up from 90 in Q3 2021.
- Funds reported $855M of Stoke Therapeutics stock for Q4 2021, up 74% quarter-over-quarter.
- 20 funds opened new Stoke Therapeutics positions in Q4 2021 and 16 closed out, a net change of +4 holders.
- The largest Stoke Therapeutics buyer in Q4 2021 was Octagon Capital Advisors, an estimated $11.6M added.
- The largest Stoke Therapeutics seller in Q4 2021 was Redmile Group, an estimated $3.23M sold.
Based on aggregated 13F filings for Q4 2021.